Report Detail

Request for Sample of this report

Other Global CAR T-Cell Immunotherapy Market 2024 by Company, Regions, Type and Application, Forecast to 2030

  • RnM3624836
    • |
  • 12 June, 2024
    • |
  • Global
    • |
  • 129 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Other

According to our (Global Info Research) latest study, the global CAR T-Cell Immunotherapy market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
CAR T-Cell Immunotherapy is a new type of cancer treatment. This emerging treatment represents one of the biggest breakthroughs since the introduction of chemotherapy. T cells is a type of white blood cell extracted from the patient’s blood by doctors, and added an artificial receptor to their surface. When infused into a patient, the cells get multiplied and stay in the body as “living drugs” and help in detecting and fighting cancer. CAR-T cell therapy is defined as a type of immunotherapy that teaches T cells to recognize and destroy cancer.
The Global Info Research report includes an overview of the development of the CAR T-Cell Immunotherapy industry chain, the market status of Hematologic Malignancies (Monotherapy, Combination Therapy), Solid Malignancies (Monotherapy, Combination Therapy), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of CAR T-Cell Immunotherapy.
Regionally, the report analyzes the CAR T-Cell Immunotherapy markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global CAR T-Cell Immunotherapy market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the CAR T-Cell Immunotherapy market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the CAR T-Cell Immunotherapy industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Monotherapy, Combination Therapy).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the CAR T-Cell Immunotherapy market.
Regional Analysis: The report involves examining the CAR T-Cell Immunotherapy market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the CAR T-Cell Immunotherapy market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to CAR T-Cell Immunotherapy:
Company Analysis: Report covers individual CAR T-Cell Immunotherapy players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards CAR T-Cell Immunotherapy This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hematologic Malignancies, Solid Malignancies).
Technology Analysis: Report covers specific technologies relevant to CAR T-Cell Immunotherapy. It assesses the current state, advancements, and potential future developments in CAR T-Cell Immunotherapy areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the CAR T-Cell Immunotherapy market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
CAR T-Cell Immunotherapy market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Monotherapy
Combination Therapy
Market segment by Application
Hematologic Malignancies
Solid Malignancies
Market segment by players, this report covers
AbbVie
Celgene
Kite Pharma
Oxford BioMedica
Novartis
Gilead
Pfizer
Cellectis
Bellicum
Mustang Bio
CARsgen Therapeutics
Xyphos
Minerva Biotechnologies
Adaptimmune
Ziopharm Oncology
Aurora Biopharma
Creative Biolabs
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe CAR T-Cell Immunotherapy product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of CAR T-Cell Immunotherapy, with revenue, gross margin and global market share of CAR T-Cell Immunotherapy from 2019 to 2024.
Chapter 3, the CAR T-Cell Immunotherapy competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and CAR T-Cell Immunotherapy market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of CAR T-Cell Immunotherapy.
Chapter 13, to describe CAR T-Cell Immunotherapy research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of CAR T-Cell Immunotherapy
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of CAR T-Cell Immunotherapy by Type
    • 1.3.1 Overview: Global CAR T-Cell Immunotherapy Market Size by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Global CAR T-Cell Immunotherapy Consumption Value Market Share by Type in 2023
    • 1.3.3 Monotherapy
    • 1.3.4 Combination Therapy
  • 1.4 Global CAR T-Cell Immunotherapy Market by Application
    • 1.4.1 Overview: Global CAR T-Cell Immunotherapy Market Size by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Hematologic Malignancies
    • 1.4.3 Solid Malignancies
  • 1.5 Global CAR T-Cell Immunotherapy Market Size & Forecast
  • 1.6 Global CAR T-Cell Immunotherapy Market Size and Forecast by Region
    • 1.6.1 Global CAR T-Cell Immunotherapy Market Size by Region: 2019 VS 2023 VS 2030
    • 1.6.2 Global CAR T-Cell Immunotherapy Market Size by Region, (2019-2030)
    • 1.6.3 North America CAR T-Cell Immunotherapy Market Size and Prospect (2019-2030)
    • 1.6.4 Europe CAR T-Cell Immunotherapy Market Size and Prospect (2019-2030)
    • 1.6.5 Asia-Pacific CAR T-Cell Immunotherapy Market Size and Prospect (2019-2030)
    • 1.6.6 South America CAR T-Cell Immunotherapy Market Size and Prospect (2019-2030)
    • 1.6.7 Middle East and Africa CAR T-Cell Immunotherapy Market Size and Prospect (2019-2030)

2 Company Profiles

  • 2.1 AbbVie
    • 2.1.1 AbbVie Details
    • 2.1.2 AbbVie Major Business
    • 2.1.3 AbbVie CAR T-Cell Immunotherapy Product and Solutions
    • 2.1.4 AbbVie CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 AbbVie Recent Developments and Future Plans
  • 2.2 Celgene
    • 2.2.1 Celgene Details
    • 2.2.2 Celgene Major Business
    • 2.2.3 Celgene CAR T-Cell Immunotherapy Product and Solutions
    • 2.2.4 Celgene CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Celgene Recent Developments and Future Plans
  • 2.3 Kite Pharma
    • 2.3.1 Kite Pharma Details
    • 2.3.2 Kite Pharma Major Business
    • 2.3.3 Kite Pharma CAR T-Cell Immunotherapy Product and Solutions
    • 2.3.4 Kite Pharma CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Kite Pharma Recent Developments and Future Plans
  • 2.4 Oxford BioMedica
    • 2.4.1 Oxford BioMedica Details
    • 2.4.2 Oxford BioMedica Major Business
    • 2.4.3 Oxford BioMedica CAR T-Cell Immunotherapy Product and Solutions
    • 2.4.4 Oxford BioMedica CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 Oxford BioMedica Recent Developments and Future Plans
  • 2.5 Novartis
    • 2.5.1 Novartis Details
    • 2.5.2 Novartis Major Business
    • 2.5.3 Novartis CAR T-Cell Immunotherapy Product and Solutions
    • 2.5.4 Novartis CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Novartis Recent Developments and Future Plans
  • 2.6 Gilead
    • 2.6.1 Gilead Details
    • 2.6.2 Gilead Major Business
    • 2.6.3 Gilead CAR T-Cell Immunotherapy Product and Solutions
    • 2.6.4 Gilead CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Gilead Recent Developments and Future Plans
  • 2.7 Pfizer
    • 2.7.1 Pfizer Details
    • 2.7.2 Pfizer Major Business
    • 2.7.3 Pfizer CAR T-Cell Immunotherapy Product and Solutions
    • 2.7.4 Pfizer CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 Pfizer Recent Developments and Future Plans
  • 2.8 Cellectis
    • 2.8.1 Cellectis Details
    • 2.8.2 Cellectis Major Business
    • 2.8.3 Cellectis CAR T-Cell Immunotherapy Product and Solutions
    • 2.8.4 Cellectis CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 Cellectis Recent Developments and Future Plans
  • 2.9 Bellicum
    • 2.9.1 Bellicum Details
    • 2.9.2 Bellicum Major Business
    • 2.9.3 Bellicum CAR T-Cell Immunotherapy Product and Solutions
    • 2.9.4 Bellicum CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 Bellicum Recent Developments and Future Plans
  • 2.10 Mustang Bio
    • 2.10.1 Mustang Bio Details
    • 2.10.2 Mustang Bio Major Business
    • 2.10.3 Mustang Bio CAR T-Cell Immunotherapy Product and Solutions
    • 2.10.4 Mustang Bio CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 Mustang Bio Recent Developments and Future Plans
  • 2.11 CARsgen Therapeutics
    • 2.11.1 CARsgen Therapeutics Details
    • 2.11.2 CARsgen Therapeutics Major Business
    • 2.11.3 CARsgen Therapeutics CAR T-Cell Immunotherapy Product and Solutions
    • 2.11.4 CARsgen Therapeutics CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2019-2024)
    • 2.11.5 CARsgen Therapeutics Recent Developments and Future Plans
  • 2.12 Xyphos
    • 2.12.1 Xyphos Details
    • 2.12.2 Xyphos Major Business
    • 2.12.3 Xyphos CAR T-Cell Immunotherapy Product and Solutions
    • 2.12.4 Xyphos CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2019-2024)
    • 2.12.5 Xyphos Recent Developments and Future Plans
  • 2.13 Minerva Biotechnologies
    • 2.13.1 Minerva Biotechnologies Details
    • 2.13.2 Minerva Biotechnologies Major Business
    • 2.13.3 Minerva Biotechnologies CAR T-Cell Immunotherapy Product and Solutions
    • 2.13.4 Minerva Biotechnologies CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2019-2024)
    • 2.13.5 Minerva Biotechnologies Recent Developments and Future Plans
  • 2.14 Adaptimmune
    • 2.14.1 Adaptimmune Details
    • 2.14.2 Adaptimmune Major Business
    • 2.14.3 Adaptimmune CAR T-Cell Immunotherapy Product and Solutions
    • 2.14.4 Adaptimmune CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2019-2024)
    • 2.14.5 Adaptimmune Recent Developments and Future Plans
  • 2.15 Ziopharm Oncology
    • 2.15.1 Ziopharm Oncology Details
    • 2.15.2 Ziopharm Oncology Major Business
    • 2.15.3 Ziopharm Oncology CAR T-Cell Immunotherapy Product and Solutions
    • 2.15.4 Ziopharm Oncology CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2019-2024)
    • 2.15.5 Ziopharm Oncology Recent Developments and Future Plans
  • 2.16 Aurora Biopharma
    • 2.16.1 Aurora Biopharma Details
    • 2.16.2 Aurora Biopharma Major Business
    • 2.16.3 Aurora Biopharma CAR T-Cell Immunotherapy Product and Solutions
    • 2.16.4 Aurora Biopharma CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2019-2024)
    • 2.16.5 Aurora Biopharma Recent Developments and Future Plans
  • 2.17 Creative Biolabs
    • 2.17.1 Creative Biolabs Details
    • 2.17.2 Creative Biolabs Major Business
    • 2.17.3 Creative Biolabs CAR T-Cell Immunotherapy Product and Solutions
    • 2.17.4 Creative Biolabs CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2019-2024)
    • 2.17.5 Creative Biolabs Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global CAR T-Cell Immunotherapy Revenue and Share by Players (2019-2024)
  • 3.2 Market Share Analysis (2023)
    • 3.2.1 Market Share of CAR T-Cell Immunotherapy by Company Revenue
    • 3.2.2 Top 3 CAR T-Cell Immunotherapy Players Market Share in 2023
    • 3.2.3 Top 6 CAR T-Cell Immunotherapy Players Market Share in 2023
  • 3.3 CAR T-Cell Immunotherapy Market: Overall Company Footprint Analysis
    • 3.3.1 CAR T-Cell Immunotherapy Market: Region Footprint
    • 3.3.2 CAR T-Cell Immunotherapy Market: Company Product Type Footprint
    • 3.3.3 CAR T-Cell Immunotherapy Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global CAR T-Cell Immunotherapy Consumption Value and Market Share by Type (2019-2024)
  • 4.2 Global CAR T-Cell Immunotherapy Market Forecast by Type (2025-2030)

5 Market Size Segment by Application

  • 5.1 Global CAR T-Cell Immunotherapy Consumption Value Market Share by Application (2019-2024)
  • 5.2 Global CAR T-Cell Immunotherapy Market Forecast by Application (2025-2030)

6 North America

  • 6.1 North America CAR T-Cell Immunotherapy Consumption Value by Type (2019-2030)
  • 6.2 North America CAR T-Cell Immunotherapy Consumption Value by Application (2019-2030)
  • 6.3 North America CAR T-Cell Immunotherapy Market Size by Country
    • 6.3.1 North America CAR T-Cell Immunotherapy Consumption Value by Country (2019-2030)
    • 6.3.2 United States CAR T-Cell Immunotherapy Market Size and Forecast (2019-2030)
    • 6.3.3 Canada CAR T-Cell Immunotherapy Market Size and Forecast (2019-2030)
    • 6.3.4 Mexico CAR T-Cell Immunotherapy Market Size and Forecast (2019-2030)

7 Europe

  • 7.1 Europe CAR T-Cell Immunotherapy Consumption Value by Type (2019-2030)
  • 7.2 Europe CAR T-Cell Immunotherapy Consumption Value by Application (2019-2030)
  • 7.3 Europe CAR T-Cell Immunotherapy Market Size by Country
    • 7.3.1 Europe CAR T-Cell Immunotherapy Consumption Value by Country (2019-2030)
    • 7.3.2 Germany CAR T-Cell Immunotherapy Market Size and Forecast (2019-2030)
    • 7.3.3 France CAR T-Cell Immunotherapy Market Size and Forecast (2019-2030)
    • 7.3.4 United Kingdom CAR T-Cell Immunotherapy Market Size and Forecast (2019-2030)
    • 7.3.5 Russia CAR T-Cell Immunotherapy Market Size and Forecast (2019-2030)
    • 7.3.6 Italy CAR T-Cell Immunotherapy Market Size and Forecast (2019-2030)

8 Asia-Pacific

  • 8.1 Asia-Pacific CAR T-Cell Immunotherapy Consumption Value by Type (2019-2030)
  • 8.2 Asia-Pacific CAR T-Cell Immunotherapy Consumption Value by Application (2019-2030)
  • 8.3 Asia-Pacific CAR T-Cell Immunotherapy Market Size by Region
    • 8.3.1 Asia-Pacific CAR T-Cell Immunotherapy Consumption Value by Region (2019-2030)
    • 8.3.2 China CAR T-Cell Immunotherapy Market Size and Forecast (2019-2030)
    • 8.3.3 Japan CAR T-Cell Immunotherapy Market Size and Forecast (2019-2030)
    • 8.3.4 South Korea CAR T-Cell Immunotherapy Market Size and Forecast (2019-2030)
    • 8.3.5 India CAR T-Cell Immunotherapy Market Size and Forecast (2019-2030)
    • 8.3.6 Southeast Asia CAR T-Cell Immunotherapy Market Size and Forecast (2019-2030)
    • 8.3.7 Australia CAR T-Cell Immunotherapy Market Size and Forecast (2019-2030)

9 South America

  • 9.1 South America CAR T-Cell Immunotherapy Consumption Value by Type (2019-2030)
  • 9.2 South America CAR T-Cell Immunotherapy Consumption Value by Application (2019-2030)
  • 9.3 South America CAR T-Cell Immunotherapy Market Size by Country
    • 9.3.1 South America CAR T-Cell Immunotherapy Consumption Value by Country (2019-2030)
    • 9.3.2 Brazil CAR T-Cell Immunotherapy Market Size and Forecast (2019-2030)
    • 9.3.3 Argentina CAR T-Cell Immunotherapy Market Size and Forecast (2019-2030)

10 Middle East & Africa

  • 10.1 Middle East & Africa CAR T-Cell Immunotherapy Consumption Value by Type (2019-2030)
  • 10.2 Middle East & Africa CAR T-Cell Immunotherapy Consumption Value by Application (2019-2030)
  • 10.3 Middle East & Africa CAR T-Cell Immunotherapy Market Size by Country
    • 10.3.1 Middle East & Africa CAR T-Cell Immunotherapy Consumption Value by Country (2019-2030)
    • 10.3.2 Turkey CAR T-Cell Immunotherapy Market Size and Forecast (2019-2030)
    • 10.3.3 Saudi Arabia CAR T-Cell Immunotherapy Market Size and Forecast (2019-2030)
    • 10.3.4 UAE CAR T-Cell Immunotherapy Market Size and Forecast (2019-2030)

11 Market Dynamics

  • 11.1 CAR T-Cell Immunotherapy Market Drivers
  • 11.2 CAR T-Cell Immunotherapy Market Restraints
  • 11.3 CAR T-Cell Immunotherapy Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 CAR T-Cell Immunotherapy Industry Chain
  • 12.2 CAR T-Cell Immunotherapy Upstream Analysis
  • 12.3 CAR T-Cell Immunotherapy Midstream Analysis
  • 12.4 CAR T-Cell Immunotherapy Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on CAR T-Cell Immunotherapy. Industry analysis & Market Report on CAR T-Cell Immunotherapy is a syndicated market report, published as Global CAR T-Cell Immunotherapy Market 2024 by Company, Regions, Type and Application, Forecast to 2030. It is complete Research Study and Industry Analysis of CAR T-Cell Immunotherapy market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,208.56
    		4,812.84
    		6,417.12
    		531,604.80
    		797,407.20
    		1,063,209.60
    		292,702.80
    		439,054.20
    		585,405.60
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo